EDGAR Filing Documents for 0001126234-13-000027

Form 8-K - Current report:

SEC Accession No. 0001126234-13-000027

Filing Date

2013-01-31

Accepted

2013-01-31 16:08:46

Documents

Period of Report

2013-01-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	NLNK-20130130-8K	nlnk-20130131x8k.htm	8-K	33658
2	UNDERWRITING AGREEMENT	nlnk-20130131xex11.htm	EX-1.1	276914
3	OPINION AND CONSENT OF COUNSEL	nlnk-20130131xex51.htm	EX-5.1	12390
4	PRESS RELEASE - OFFERING	nlnk-20130131xex991.htm	EX-99.1	9138
5	PRESS RELEASE - PRICING	nlnk-20130131xex992.htm	EX-99.2	9229
6	GRAHPIC	legallogo.jpg	GRAPHIC	11014
7	GRAPHIC	logo8k20130131.jpg	GRAPHIC	20255
	Complete submission text file	0001126234-13-000027.txt		385801

Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010

Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555

NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 13562722
SIC: 2834 Pharmaceutical Preparations